Recombinant Mycobacterium bovis Glycine dehydrogenase [decarboxylating] (gcvP), partial

Shipped with Ice Packs
In Stock

Description

Recombinant Expression Systems

The protein is produced using advanced genetic engineering strategies to ensure solubility and functionality:

Expression HostTagging StrategyPurityApplication
E. coliC-terminal or N-terminal His-tag>85%Vaccine research, enzymatic assays
BaculovirusFlexible linker-fused constructs>90%Structural studies
  • Optimization: For challenging proteins, fusion tags (e.g., GFP, SUMO) or concatenated ORFs (e.g., PPE-PE pairs) improve stability .

  • Validation: Western blotting with anti-His antibodies confirms expression, with degradation or oligomerization observed in some cases .

Functional Role in Glycine Metabolism

The GCS pathway is indispensable for bacterial survival, enabling:

  • One-Carbon Metabolism: Glycine degradation supplies methylene tetrahydrofolate for nucleotide synthesis .

  • Pathogenesis: GCS proteins like gcvP are implicated in bacterial evasion of host immune responses. For example, Mycoplasma GcvH (a GCS subunit) inhibits apoptosis by stabilizing ER-resident kinases . While M. bovis gcvP’s direct role in immune modulation remains understudied, its metabolic contribution likely supports persistent infection .

Vaccine Development

  • Antigen Candidate: Recombinant gcvP is explored as a subunit vaccine component against bovine tuberculosis (bTB). Its immunogenicity is enhanced when paired with adjuvants or delivery systems like BCG vectors .

  • Challenges: Low solubility and stability in native forms necessitate recombinant engineering for scalable production .

Enzymatic Studies

  • Kinetic Analysis: Studies on homologous Mycobacterium gilvum gcvP reveal optimal activity at neutral pH and 37°C, with a Km value of 2.5 mM for glycine .

Comparative Expression of Recombinant gcvP Homologs

SpeciesExpression HostAmino Acid RangeMolecular WeightReference
M. bovis (hypothetical)E. coli1–941~105 kDa
M. gilvumE. coli1–952~110 kDa

Key Research Milestones

  • 2022: Frontiers in Molecular Biosciences highlighted recombinant M. bovis proteins, including gcvP, as potential vaccine targets .

  • 2024: PLOS Pathogens elucidated the anti-apoptotic role of GCS proteins in Mycoplasma, suggesting analogous mechanisms in M. bovis .

Future Directions

Further studies are needed to:

  • Characterize M. bovis gcvP’s structural domains and catalytic residues.

  • Evaluate its efficacy in animal vaccine trials.

  • Explore interactions with host immune cells during infection.

Product Specs

Form
Lyophilized powder. We will ship the available format, but you can request a specific format when ordering.
Lead Time
Delivery times vary. Consult local distributors for specifics. Proteins are shipped with blue ice packs. Dry ice shipping is available upon request for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots are stable at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
gcvP; JTY_1851Glycine dehydrogenase; decarboxylating; EC 1.4.4.2; Glycine cleavage system P-protein; Glycine decarboxylase; Glycine dehydrogenase; aminomethyl-transferring)
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Mycobacterium bovis (strain BCG / Tokyo 172 / ATCC 35737 / TMC 1019)
Target Names
gcvP
Uniprot No.

Target Background

Function
Glycine dehydrogenase (decarboxylating) (gcvP) is part of the glycine cleavage system, which degrades glycine. The P protein uses its pyridoxal phosphate cofactor to bind glycine, releasing CO2. The remaining methylamine is transferred to the H protein's lipoamide cofactor.
Database Links

KEGG: mbt:JTY_1851

Protein Families
GcvP family

Q&A

What is the glycine cleavage system and how does gcvP function within it?

The glycine cleavage system (GCS) is a multi-enzyme complex that catalyzes the reversible oxidation of glycine. In Mycobacterium bovis, as in other organisms, this system consists of four main protein components:

  • gcvP (P-protein): A pyridoxal phosphate-dependent glycine decarboxylase

  • gcvH (H-protein): A lipoic acid-containing carrier protein

  • gcvT (T-protein): A tetrahydrofolate-dependent enzyme

  • gcvL (L-protein): A dihydrolipoamide dehydrogenase

How conserved is the gcvP gene across different mycobacterial species?

Southern blot hybridization analysis reveals that the glycine cleavage system genes are widely conserved across rhizobia species, with variable genomic organization. Similar conservation patterns are likely present in mycobacterial species. When probing for gcvT (a companion protein to gcvP in the glycine cleavage system), hybridization patterns show significant conservation with some species exhibiting multiple copies of these genes .

Bacterial SpeciesEcoRI Fragment PatternNumber of gcv Copies
S. fredii USDA205Two strongly hybridizing fragmentsPotentially 2
S. saheli USDA4894Two strongly hybridizing fragmentsPotentially 2
Other Sinorhizobium speciesSingle hybridizing fragmentLikely 1

Complete genome sequences of related bacteria confirm the presence of the gcv locus across multiple species, suggesting evolutionary importance of this metabolic pathway .

What are the optimal expression systems for recombinant M. bovis gcvP?

Based on successful expression of other mycobacterial proteins, several systems can be employed for gcvP expression:

  • Bacterial expression: While E. coli is commonly used for protein expression, mycobacterial proteins often exhibit better expression and folding in mycobacterial hosts like M. smegmatis.

  • Yeast expression: Komagataella phaffii (formerly Pichia pastoris) has proven effective for expressing complex dehydrogenases, as demonstrated with human dimethylglycine dehydrogenase (hDMGDH) .

  • Intracellular vs. secreted expression: For successful purification, intracellular expression in K. phaffii has shown better results than secretion-based approaches for similar dehydrogenases .

Methodological approach:

When establishing an expression system, create multiple constructs with different promoters (constitutive vs. inducible), solubility tags, and host strains. Compare expression levels through small-scale expression tests before scaling up to production levels.

What purification strategies yield the highest purity and activity of recombinant gcvP?

A multi-step purification approach is recommended:

  • Initial capture: Affinity chromatography using His-tag or other fusion tags

  • Intermediate purification: Ion exchange chromatography

  • Final polishing: Size exclusion chromatography

For glycine dehydrogenase, activity preservation during purification is critical. Based on related enzymes, the following buffer conditions are recommended:

Purification StepBuffer CompositionCritical Parameters
Cell Lysis50 mM phosphate buffer, pH 7.5, 300 mM NaCl, 10% glycerol, protease inhibitorsMaintain temperature at 4°C
Affinity ChromatographySame as lysis + 10-250 mM imidazole gradientSlow flow rate (0.5-1 ml/min)
Ion Exchange20 mM Tris-HCl, pH 8.0, 0-500 mM NaCl gradientMonitor activity of eluted fractions
Size Exclusion50 mM phosphate buffer, pH 7.5, 150 mM NaCl, 5% glycerolAnalyze fractions by SDS-PAGE

Include pyridoxal 5'-phosphate (PLP) at 50 μM throughout purification to maintain cofactor binding and enzyme stability .

How can the enzymatic activity of purified gcvP be accurately measured?

Since gcvP functions as part of a multi-component system, activity assays require careful design:

Primary assay methods:

For steady-state kinetics determination, the spectrophotometric assay using DCPIP provides reliable data, as demonstrated with similar dehydrogenases .

What cofactors are essential for gcvP activity and how do they affect enzyme function?

Based on related dehydrogenases, gcvP requires specific cofactors:

  • Pyridoxal 5'-phosphate (PLP): Covalently bound to a lysine residue in the active site, essential for the decarboxylation reaction.

  • Tetrahydrofolate (THF): While not directly bound to gcvP, it is required by the gcvT component to accept the transferred methyl group and prevent formaldehyde release .

When studying gcvP in isolation, the following cofactor considerations are critical:

CofactorConcentration RangeStorage StabilityFunction
PLP50-100 μMSensitive to lightSchiff base formation with substrate
THF0.5-1 mMOxygen-sensitiveMethyl group acceptor in full system
FADRequired for L-proteinRelatively stableElectron transfer in full system

Pre-incubation with PLP before activity assays is recommended to ensure maximum incorporation of the cofactor .

How can site-directed mutagenesis be utilized to investigate critical residues in gcvP?

Site-directed mutagenesis provides powerful insights into structure-function relationships. For gcvP, consider these approaches:

Methodological workflow:

  • Identify conserved residues through multiple sequence alignment of gcvP from different mycobacterial species

  • Predict critical residues based on:

    • Known catalytic residues in related dehydrogenases

    • PLP-binding motifs

    • Interface regions that interact with gcvH

  • Generate single point mutations using PCR-based methods:

    • Alanine scanning of suspected catalytic residues

    • Conservative substitutions to probe specific interactions

    • Charge reversal mutations to test electrostatic interactions

  • Express and purify mutant proteins using identical conditions to wild-type

  • Characterize mutants through:

    • Steady-state kinetics

    • Cofactor binding assays

    • Protein-protein interaction studies with gcvH

    • Thermal stability measurements

What are the methods for analyzing pre-steady-state kinetics of gcvP and what insights do they provide?

Pre-steady-state kinetics reveal individual steps in the reaction mechanism:

Methodological approach:

  • Stopped-flow spectroscopy:

    • Monitor rapid changes in intrinsic protein fluorescence

    • Track formation/decay of reaction intermediates

    • Measure rates of substrate binding and product release

  • Experimental design considerations:

    • Use various substrate concentrations to determine binding constants

    • Temperature dependence studies to calculate activation energies

    • pH dependence to identify critical ionizable groups

  • Data analysis methods:

    • Fit time courses to appropriate exponential equations

    • Global fitting of multiple datasets

    • Kinetic simulation to test mechanistic models

Similar studies with human DMGDH revealed a reductive rate of 17 ± 0.3 s^-1 and a dissociation constant of 4.9 ± 0.3 mM for the substrate .

How can the three-dimensional structure of gcvP be determined and what challenges might arise?

Several approaches can be used to determine gcvP structure:

X-ray crystallography methodology:

  • Crystal optimization:

    • Screen various buffer conditions, precipitants, and additives

    • Include cofactors (PLP) during crystallization

    • Consider crystallization with substrate analogs

  • Data collection considerations:

    • Cryoprotection optimization

    • Synchrotron radiation for high-resolution data

    • Multiple wavelength anomalous dispersion (MAD) for phase determination

  • Structure refinement:

    • Molecular replacement using related dehydrogenases as search models

    • Validation of cofactor binding sites

    • Analysis of oligomerization state

How do substrate-binding dynamics affect catalytic activity in gcvP?

Understanding substrate binding requires sophisticated biophysical techniques:

Methodological approaches:

  • Isothermal titration calorimetry (ITC):

    • Direct measurement of binding thermodynamics

    • Determine binding affinity, enthalpy, and stoichiometry

    • Analyze effects of temperature and buffer conditions

  • Surface plasmon resonance (SPR):

    • Real-time binding kinetics

    • Association and dissociation rate constants

    • Competition assays with substrate analogs

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS):

    • Map conformational changes upon substrate binding

    • Identify flexible regions involved in catalysis

    • Detect allosteric effects of substrate binding

How can gcvP gene disruption studies inform our understanding of M. bovis metabolism?

Gene disruption provides insights into the physiological importance of gcvP:

Methodological workflow:

  • Generation of deletion mutants:

    • Creation of knockout constructs using suicide plasmids

    • Use of Ω-fragments for insertion mutagenesis

    • Selection on appropriate media (e.g., sucrose-containing media for sacB counter-selection)

  • Confirmation of gene disruption:

    • Southern blot hybridization

    • PCR verification

    • RT-PCR to confirm absence of transcript

    • Western blot to verify protein absence

  • Phenotypic characterization:

    • Growth kinetics in different carbon sources

    • Metabolite profiling using LC-MS/MS

    • Transcriptomic analysis to identify compensatory pathways

    • In vivo growth in macrophages or animal models

Similar approaches with glycine cleavage system mutants in other bacteria have revealed essential roles in metabolism and virulence .

How does the substrate specificity of M. bovis gcvP compare with similar enzymes from other bacteria?

Comparative enzymology reveals evolutionary adaptations:

Methodological approach:

  • Expression and purification of orthologous enzymes:

    • Clone gcvP from multiple bacterial species

    • Express under identical conditions

    • Purify to homogeneity using standardized protocols

  • Substrate specificity profiling:

    • Test activity with glycine analogs

    • Determine kinetic parameters for each substrate

    • Compare inhibition patterns with various compounds

  • Structural comparison:

    • Homology modeling based on available structures

    • Docking studies with different substrates

    • Identification of species-specific substrate binding residues

The substrate profile of Mycobacterium dehydrogenases may show distinct preferences compared to other bacterial enzymes, similar to how M. bovis alcohol dehydrogenase shows preferences for certain aldehydes (benzaldehyde > 3-methoxybenzaldehyde > octanal > coniferaldehyde) .

What strategies can overcome common challenges in recombinant gcvP expression?

When expression yields are low or protein is inactive, consider these approaches:

Methodological solutions:

  • For inclusion body formation:

    • Lower induction temperature (16-20°C)

    • Reduce inducer concentration

    • Co-express with chaperones (GroEL/GroES, DnaK/DnaJ)

    • Add solubility tags (MBP, SUMO, TrxA)

  • For poor cofactor incorporation:

    • Supplement growth media with pyridoxine

    • Add PLP during cell lysis and purification

    • Reconstitute with excess PLP followed by dialysis

  • For protein instability:

    • Screen buffer additives (glycerol, arginine, trehalose)

    • Add reducing agents to prevent oxidation

    • Optimize pH and ionic strength

    • Store with cofactors present

ProblemPrimary CauseSolution StrategySuccess Indicator
Low expressionCodon biasCodon optimization or use of Rosetta strainsIncreased protein yield
Inclusion bodiesRapid foldingLower temperature, slower inductionIncreased soluble fraction
Inactive enzymeCofactor lossPLP supplementationRestoration of activity
Protein degradationProtease activityProtease inhibitors, shorter purificationIntact protein on SDS-PAGE

How can contradictory experimental results in gcvP characterization be reconciled?

Resolving experimental discrepancies requires systematic troubleshooting:

Methodological approach to contradictions:

  • Enzyme activity variations:

    • Standardize assay conditions (temperature, pH, buffer components)

    • Use internal controls across experiments

    • Verify enzyme concentration by active site titration

    • Account for batch-to-batch variations in specific activity

  • Kinetic parameter discrepancies:

    • Ensure measurements are made under true initial velocity conditions

    • Verify linearity of assays with respect to time and enzyme concentration

    • Consider substrate inhibition or activation effects

    • Use global fitting approaches for complex kinetic mechanisms

  • Structure-function relationship contradictions:

    • Verify protein folding by circular dichroism

    • Confirm cofactor incorporation through spectroscopic methods

    • Use multiple complementary techniques to validate findings

    • Consider the impact of experimental conditions on protein conformation

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.